News Contact Us

Telix signs PI Medical as distribution partner in Netherlands

Author : Pankaj Singh | Published Date : 2019-07-03 

PI Medical to receive exclusive rights to distribution of TLX591- CDx in Netherlands

Australia headquartered - Telix Pharmaceuticals, a clinical stage biopharma company has reportedly signed Netherlands- based PI Medical Diagnostic Equipment for the distribution of TLX591-CDx cold kit in Netherlands.

For the record, Telix Pharmaceuticals focuses on the development of therapeutic and diagnostic development of products based on molecularly targeted radiation (MTR). Based in Melbourne, the company has international presence in Japan, Europe and United States. Currently, the company is developing a portfolio of clinical stage cancer treatment products that meet the required need for brain, renal and prostate cancer treatment.

Ludovic Wouters, VP Corporate Development at Telix Pharmaceuticals was reportedly quoted stating that for several months the company has been informally researching and working with the PI Medical and aim at establishing a concrete commercial relationship focusing on the availability of PSMA imaging cold kit. With the help of PI Medical’s nuclear medicine expertise and their recognition in the market, Telix Pharmaceuticals can easily establish itself in the Dutch market, he further stated.

PI Medical Diagnostic Equipment was founded in January 1995 and is a commercially strong Netherlands based company produces nuclear medicines and focuses on radiology and radiotherapy market. The company has developed equipments for sentinel gland procedures. The products range from nuclear medicines, radiotherapy, radiology to operating rooms.

The Managing Director of PI Medical reportedly claimed that the collaborating companies complement each other, concerning PI’s expertise in nuclear medicines and Telix’s products. The theranostic product portfolio of the company includes gallium-based products and the use of Lutetium- 177, a therapeutic isotope, he added.

The collaboration is a multi-product agreement whereby PI Medical will receive the exclusive rights to the distribution of TLX591 – CDx, a prostate cancer imaging in Netherlands and non- exclusive distribution rights in the Flemish region of Belgium.

Reportedly, the financial details related to the deal have not been disclosed so far.

Source Credits: https://www.globenewswire.com/news-release/2019/07/02/1877033/0/en/Telix-Pharmaceuticals-and-PI-Medical-Sign-Distribution-Agreement-for-the-Netherlands.html

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Facebook to roll out officially licensed music videos on its platform

Published Date: 2020-07-16         Author: Pankaj Singh

California-based social media giant Facebook has reportedly announced its plans to officially launch licensed music videos on its social networking platform in the U.S. The social media major has already told Page owners, who are connected to artists, that they will have to toggle on a new setting t... Read More

Google to invest $10bn in India to drive digital transformation

Published Date: 2020-07-15         Author: Pankaj Singh

Speaking at the annual Google India online event, CEO Sunder Pichai has announced that Google will invest $10 billion in India over the next five to seven years through the ‘Google for India Digitization fund’. According to sources familiar with the knowledge of the matter, the funds ... Read More

Sir Richard Branson to contribute £200M to stabilize Virgin Atlantic

Published Date: 2020-07-14         Author: Pankaj Singh

British business magnate Sir Richard Branson had reportedly announced that he intends to contribute a sum of £200 million as part of the £1 billion plan to stabilize Virgin Atlantic without taxpayers’ money. Sources state that he will use the funds raised by selling a £396 mi... Read More

© 2020 Fractovia. All Rights Reserved